Effect of lipid environment on amyloid fibril formation of human serum amyloid A

Abedini, 2009, A critical assessment of the role of helical intermediates in amyloid formation by natively unfolded proteins and polypeptides, Protein Eng. Des. Sel., 22, 453, 10.1093/protein/gzp036 Adachi, 2013, Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation, J. Biol. Chem., 288, 2848, 10.1074/jbc.M112.428052 Bartlett, 1959, Phosphorus assay in column chromatography, J. Biol. Chem., 234, 466, 10.1016/S0021-9258(18)70226-3 Bruni, 1982, Lysophosphatidylserine, a short-lived intermediate with plasma membrane regulatory properties, Pharmacol. Res. Commun., 14, 469, 10.1016/S0031-6989(82)80038-6 Caillon, 2013, Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation, Biochim. Biophys. Acta, 1828, 2091, 10.1016/j.bbamem.2013.05.014 Coetzee, 1986, Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition, J. Biol. Chem., 261, 9644, 10.1016/S0021-9258(18)67562-3 Egashira, 2011, Identification of regions responsible for heparin-induced amyloidogenesis of human serum amyloid A using its fragment peptides, Arch. Biochem. Biophys., 511, 101, 10.1016/j.abb.2011.04.019 Fezoui, 2002, Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization, J. Biol. Chem., 277, 36948, 10.1074/jbc.M204168200 Hatters, 2000, Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops, Biochemistry, 39, 8276, 10.1021/bi000002w Hou, 2008, Cholesterol and anionic phospholipids increase the binding of amyloidogenic transthyretin to lipid membranes, Biochim. Biophys. Acta, 1778, 198, 10.1016/j.bbamem.2007.09.018 Kakio, 2002, Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid, Biochemistry, 41, 7385, 10.1021/bi0255874 Li, 2004, The critical micelle concentrations of lysophosphatidic acid and sphingosylphosphorylcholine, Chem. Phys. Lipids, 130, 197, 10.1016/j.chemphyslip.2004.03.001 Lu, 2014, Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis, Proc. Natl. Acad. Sci. U. S. A., 111, 5189, 10.1073/pnas.1322357111 Mahalka, 2011, 1-Palmitoyl-2-(9'-oxononanoyl)-sn-glycero-3-phosphocholine, an oxidized phospholipid, accelerates finnish type familial gelsolin amyloidosis in vitro, Biochemistry, 50, 4877, 10.1021/bi200195s Micsonai, 2015, Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy, Proc. Natl. Acad. Sci. U S A., 112, E3095, 10.1073/pnas.1500851112 Murphy, 2007, Kinetics of amyloid formation and membrane interaction with amyloidogenic proteins, Biochim. Biophys. Acta, 1768, 1923, 10.1016/j.bbamem.2006.12.014 Noborn, 2012, Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation, J. Biol. Chem., 287, 25669, 10.1074/jbc.M112.363895 Ohta, 2009, Defining lipid-binding regions of human serum amyloid A using its fragment peptides, Chem. Phys. Lipids, 162, 62, 10.1016/j.chemphyslip.2009.07.008 Rosso, 2014, Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammation, Atherosclerosis, 237, 652, 10.1016/j.atherosclerosis.2014.09.034 Ryan, 2011, High-affinity amphipathic modulators of amyloid fibril nucleation and elongation, J. Mol. Biol., 406, 416, 10.1016/j.jmb.2010.12.023 Saito, 2004, Alpha-helix formation is required for high affinity binding of human apolipoprotein A-I to lipids, J. Biol. Chem., 279, 20974, 10.1074/jbc.M402043200 Stafford, 1989, Interfacial properties and critical micelle concentration of lysophospholipids, Biochemistry, 28, 5113, 10.1021/bi00438a031 Takase, 2014, Characterization of reconstituted high-density lipoprotein particles formed by lipid interactions with human serum amyloid A, Biochim. Biophys. Acta, 1842, 1467, 10.1016/j.bbalip.2014.07.012 Takase, 2014, Effect of amino acid variations in the central region of human serum amyloid A on the amyloidogenic properties, Biochem. Biophys. Res. Commun., 444, 92, 10.1016/j.bbrc.2014.01.029 Takase, 2016, Structural requirements of glycosaminoglycans for facilitating amyloid fibril formation of human serum amyloid A, Amyloid, 23, 67, 10.3109/13506129.2016.1168292 Uhlar, 1999, Serum amyloid A, the major vertebrate acute-phase reactant, Eur. J. Biochem., 265, 501, 10.1046/j.1432-1327.1999.00657.x van der Westhuyzen, 2007, HDL cholesterol transport during inflammation, Curr. Opin. Lipidol., 18, 147, 10.1097/MOL.0b013e328051b4fe Westermark, 2015, AA amyloidosis: pathogenesis and targeted therapy, Annu. Rev. Pathol., 10, 321, 10.1146/annurev-pathol-020712-163913 Yamanaka, 1997, Surface chemical properties of homologs and analogs of lysophosphatidylcholine and lysophosphatidylethanolamine in water, Chem. Phys. Lipids, 90, 97, 10.1016/S0009-3084(97)00088-1 Zhao, 2004, Formation of amyloid fibers triggered by phosphatidylserine-containing membranes, Biochemistry, 43, 10302, 10.1021/bi049002c